Wellington Management Group
MLTX icon

Wellington Management Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Wellington Management Group’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,390
Closed -$1.01M – 2056
2025
Q2 		$1.01M Sell
21,390
-10,773
-33% -$439K ﹤0.01% 1720
2025
Q1 		$1.26M Sell
32,163
-66,935
-68% -$2.88M ﹤0.01% 1655
2024
Q4 		$5.37M Sell
99,098
-92,960
-48% -$4.75M ﹤0.01% 1334
2024
Q3 		$9.68M Sell
192,058
-180,599
-48% -$8.46M ﹤0.01% 1183
2024
Q2 		$16.4M Buy
372,657
+96,218
+35% +$4.08M ﹤0.01% 1009
2024
Q1 		$13.9M Buy
276,439
+19,247
+7% +$1.04M ﹤0.01% 1036
2023
Q4 		$15.5M Sell
257,192
-166,195
-39% -$8.57M ﹤0.01% 1005
2023
Q3 		$24.1M Buy
423,387
+10,118
+2% +$559K ﹤0.01% 899
2023
Q2 		$21.1M Buy
+413,269
New +$11.1M ﹤0.01% 931
2021
Q4 		– Sell
-483,887
Closed -$4.78M – 2251
2021
Q3 		$4.78M Sell
483,887
-32,409
-6% -$323K ﹤0.01% 1519
2021
Q2 		$5.33M Sell
516,296
-10,429
-2% -$106K ﹤0.01% 1489
2021
Q1 		$5.38M Sell
526,725
-173,275
-25% -$1.91M ﹤0.01% 1409
2020
Q4 		$7.58M Buy
+700,000
New +$7.43M ﹤0.01% 1245

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wellington Management Group's MLTX Position: Q3 2025 in Review

Wellington Management Group sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2025, closing a stake of 21,390 shares — an estimated $1.01M sold.

Wellington Management Group first reported a position in MLTX in Q4 2020 and held it in 13 quarters. The position peaked at $24.1M in Q3 2023. 134 funds tracked by Wall St. Rank hold MLTX as of Q3 2025.

  • Wellington Management Group reported no remaining MoonLake Immunotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 21,390 MoonLake Immunotherapeutics shares in Q3 2025, an estimated $1.01M.
  • Wellington Management Group first reported a position in MoonLake Immunotherapeutics in Q4 2020 and held it in 13 quarters.
  • Wellington Management Group's MoonLake Immunotherapeutics position peaked at $24.1M in Q3 2023.
  • 134 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.